COVID-19 trials registries data warehouse

 Return to trial list

Trial - IRCT20200329046892N2


Column Value
Trial registration number IRCT20200329046892N2
Full text link
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

First author
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Dr. Mohammadreza Naghipour

Contact
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

research@gums.ac.ir

Registration date
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2021-03-09

Recruitment status
Last imported at : June 15, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Completed

Study design
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

RCT

Allocation
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Randomized

Design
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Parallel

Masking
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Blind label

Center
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

single-center

Study aim
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Treatment

Inclusion criteria
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

All patients with severe Covid-19 admitted to the ICU of Razi Hospital in Rasht for period of March- June 2021 Age greater than or equal to 18 years Patients admitted with the following criteria: fever (oral temperature greater than 37.2 ° C), dry cough, severe tiredness or dyspnea At least one of the following criteria : positive PCR OR lung involvement on chest X-ray / CT scan Absolute lymphocyte count greater than or equal to 200 per cubic millimeter Absolute neutrophil count greater than or equal to 1000 per milliliter Cubic meters Hemoglobin above 8 grams per deciliter

Exclusion criteria
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Lack of informed consent Lack of patient cooperation Having pulmonary embolism or intravascular thrombosis Having another active infection Having diverticulitis and gastric ulcer Having tuberculosis or hepatitis B or active hepatitis C or HIV Any major drug interaction between routine patient's drugs with any of the study drugs Pregnancy and lactation Simultaneous presence in other research study

Number of arms
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2

Funding
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Rasht University of Medical Sciences

Inclusion age min
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

18

Inclusion age max
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

100

Countries
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Iran

Type of patients
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Severe disease at enrollment

Severity scale
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

6: Severe disease at enrollment

Total sample size
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

60

primary outcome
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

The time required to improve clinical symptoms and within 14 days of treatment start

Notes
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase 2/Phase 3

Arms
Last imported at : March 10, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

[{"arm_notes": "", "treatment_id": 1300, "treatment_name": "Tofacitinib", "treatment_type": "Kinase inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]